STAND. COM. REP. NO.  1375

 

Honolulu, Hawaii

                , 2017

 

RE:   S.B. No. 174

      S.D. 2

      H.D. 1

 

 

 

 

Honorable Joseph M. Souki

Speaker, House of Representatives

Twenty-Ninth State Legislature

Regular Session of 2017

State of Hawaii

 

Sir:

 

     Your Committee on Health, to which was referred S.B. No. 174, S.D. 2, entitled:

 

"A BILL FOR AN ACT RELATING TO MEDICAL MARIJUANA,"

 

begs leave to report as follows:

 

     The purpose of this measure is to add lupus, epilepsy, multiple sclerosis, arthritis, and autism to the list of debilitating medical conditions that an individual may treat using medical marijuana in Hawaii.

 

     Your Committee received testimony in support of this measure from The Drug Policy Forum of Hawaii, Hawaii Association of Professional Nurses, Hawaii Educational Association for Licensed Therapeutic Healthcare, Maui Grown Therapies, and several individuals.  Your Committee received testimony in opposition to this measure from the Department of Health and Department of the Prosecuting Attorney of the City and County of Honolulu.  The Department of the Attorney General and an individual submitted comments.

 

     Your Committee has amended this measure by:

 

     (1)  Adding a purpose and findings section;

 

     (2)  Changing its effective date to July 1, 2070, to support further discussion; and

 

     (3)  Making technical, nonsubstantive amendments for the purposes of clarity and consistency.

 

     As affirmed by the record of votes of the members of your Committee on Health that is attached to this report, your Committee is in accord with the intent and purpose of S.B. No. 174, S.D. 2, as amended herein, and recommends that it pass Second Reading in the form attached hereto as S.B. No. 174, S.D. 2, H.D. 1, and be referred to your Committee on Judiciary.

 

 

Respectfully submitted on behalf of the members of the Committee on Health,

 

 

 

 

____________________________

DELLA AU BELATTI, Chair